9th 3D Tissue Models Summit 2024
Evvnt Promotion / evvnt
Archivio
21.05.2024 - 23.05.2024 Omni Parker House, 60 School St, 02108 Boston, Massachusetts, USA
Time: 9:00 AM - 2:00 PM
Temi della conferenza
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2224592-3?pid=4832
Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more
Brochure: https://go.evvnt.com/2224592-3?pid=4832
Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2224592-2?pid=4832
Mr. Alex Domingo
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
